Back to Journals » ClinicoEconomics and Outcomes Research » Volume 15

Cost-Effectiveness of Lorlatinib for the Treatment of Adult Patients with Anaplastic Lymphoma Kinase Positive Advanced Non-Small Cell Lung Cancer in Spain

Total article views   HTML views PDF downloads Totals
3,323 Dovepress* 2,985+ 65 3,050
PubMed Central* 338 87 425
Totals 3,323 152 3,475
*Since 7 September 2023
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 1 0 1

View citations on PubMed Central and Google Scholar